EQT to acquire the TachoSil® biosurgery business from Corza Medical
EQT to acquire Corza Biosurgery, a premier biosurgery business built around TachoSil, a leading hemostat and sealant patch used across a wide range of surgical specialties TachoSil supports improved surgical outcomes through rapid bleeding control and tissue sealing, and is backed by...
EQT to acquire Corza Biosurgery, a premier biosurgery business built around TachoSil, a leading hemostat and sealant patch used across a wide range of surgical specialties TachoSil supports improved surgical outcomes through rapid bleeding control and tissue sealing, and is backed by...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.